We describe the synthesis and pairing properties of the novel DNA analogue 7',5'-bicyclo(bc)-DNA. In this analogue, the point of attachment of the connecting phosphodiester group is switched from the 3'-to the 7'-position of the underlying bicyclic sugar unit and is thus in a topological position that is inaccessible in natural DNA. The corresponding phosphoramidite building blocks carrying all natural nucleobases were synthesized and incorporated into oligonucleotides. From Tm-experiments of duplexes with complementary DNA and RNA we find that single modifications are generally well tolerated with some variability as to the nature of the nucleobase. Fully modified oligonucleotides show low affinity for RNA and DNA complements.
Introduction
The molecular storage and retrieval system for genetic information in all forms of life on earth is DNA and RNA. The question on why nature chose this particular molecular structure as the genetic material has been a matter of debate since the structure and function of the nucleic acids became known. [1] One way to approach this question experimentally is to design alternative nucleic acid structures and test their chemical properties with respect to criteria deemed to be important for function. The generally accepted minimal requirements for function comprise the ability for complementary base-pair formation, for self-replication, for sequence evolution and for performing basic cellular metabolism. Along these lines a whole set of hexose-, pentose-and tetrose-derived nucleic acid alternatives such as hexopyranosyl-, [2] source: https://doi.org/10.7892/boris.101327 | downloaded: 30.3.2020 pentopyranosyl- [3] or pentofuranosyl-RNAs [4] have been investigated. Their characteristics as potential prebiotic genetic material has been reviewed by A. Eschenmoser, who pioneered the field in the late eighties. [5] Besides this, other minimal nucleic acid modifications such as the glycol nucleic acids (GNA) [6] and the peptide nucleic acids (PNA) [7] have been investigated in this context. A significant area of synthetic biology is concerned with the design of artificial, DNA-like genetic systems. A basic requirement to achieve this goal is the development of synthetic genetic polymers, often referred to as xeno-nucleic acids (XNA), that fulfill the function of DNA but that are non-existent in nature. [8] The availability of such systems and their integration into living organisms is expected to equip them with novel properties that are of interest in biotechnology and medicine. From the vast repertoire of nucleic acid modifications that appeared over the last 30 years, a handful of candidates has been scrutinized towards their suitability as an alternative genetic material. To introduce non-natural components into the natural genetic machinery by minimal chemical alteration it has been shown that thymidine in the genome of E. coli strains, lacking thymidylate synthase, can be replaced by 5-chlorouridine in an evolutionary process to a minimum residual thymidine content of less than 2%. [9] In a different approach it has been reported that unnatural nucleic acids such as hexitol nucleic acids (HNA), [10] cyclohexenyl nucleic acids (CeNA), [11] 2'-fluoroarabino nucleic acids (FANA), [12] arabino nucleic acids (ANA), [13] threose nucleic acids (TNA) [4] and locked nucleic acids (LNA) [14] can be transcribed from and reverse transcribed into DNA by DNA-polymerases obtained from in vitro evolution. [15] Likewise, it has been shown recently that HNA, CeNA, FANA and ANA can be transformed into catalysts (XNAzymes) by SELEX methods utilizing such engineered polymerases, demonstrating that XNAs with alternative backbone structures can fold into active species capable to perform simple chemical steps. [16] An attempt to explore the amenable structural space of known XNAs beyond that occupied by DNA and RNA has recently been performed by comparing known duplex structures in the protein data bank. [17] A seemingly minimal alteration of the backbone structure of RNA and DNA results when changing the point of attachment of the internucleoside phosphate unit from the 3' to the 2' oxygen (2',5'-DNA or 2',5'-RNA). While 2',5'-RNA is a naturally occurring biopolymer, first found in bacteria in the form of 2',5' polyadenylates, [18] 2',5'-DNA is artificial. The pairing and replication properties of both polymers have been investigated in the past. It was found that 2',5'-RNA binds to complementary RNA but not to DNA. Duplexes with RNA are slightly less stable as compared to pure RNA duplexes and duplexes in the pure 2',5'-RNA series exist but are even less stable. [19] The same holds true also for 2',5'-DNA. [20] An NMR structural analysis of a self-complementary 2',5'-DNA duplex reveals a conformation that is close to A-type, showing nucleoside puckers that alternate between S-and N-conformation along the nucleotide chain. [21] In addition, it was shown in primer template extension experiments that stretches of up to four 2',5'-linked nucleotides on a template can be reverse transcribed into DNA with polymerases or reverse transcriptases even though there is no significant affinity of 2',5'-DNA to natural DNA. [22] In continuing efforts to understand the structure/affinity relationship in nucleic acid analogues we became interested in investigating an artificial nucleic acid system in which the point of attachment of the phosphodiester unit is shifted by the same distance as in 2',5'-DNA, but in the opposite direction (Figure 1, top left) . A simple, conformationally not constrained extension of the backbone by inserting a methylene unit between C3' and O3' has been explored in the past. These studies revealed that incorporation of such thymidine homologues, either in the -or -configuration, into NMR NOESY experiments (see Supp. Inf.) and by X-ray crystallography (see below). Final phosphitylation with 2cyanoethyl-N,N,N′,N′-tetraisopropyl phosphordiamidite lead to the thymidine phosphoramidite building block 12. The synthesis of the 5-methylcytidine analogue was achieved by conversion of the base thymine into 5-methylcytosine in nucleoside 11. To this end, nucleoside 11 was TMS protected and converted to the corresponding triazolide by treatment with 1,2,4-triazole and POCl3. Subsequent treatment of this triazolide in a mixture of ammonia and 1,4-dioxane yielded the corresponding 5-methylcytosine nucleoside, which was directly protected with Bz2O to give 13 in 88% yield over three steps. The phosphoramidite 14 was obtained by phosphitylation as described above.
The introduction of the purine nucleobases proved to be more problematic. Classical Vorbrüggen nucleosidation resulted generally in the prevalence of the undesired -nucleosides. In the absence of other stereoselective alternatives, and based on our interest in the -nucleosides in a different context, we nevertheless decided to follow this reaction pathway and converted precursor 7 with either N 6 -benzoyladenine or 2-amino-6-chloropurine to the inseparable anomeric mixtures 15a/b and 20a/b, resp. in α/β ratios of 4:1 and 7:3 (Scheme 3). Separation of anomers was possible only after deacetylation, leading to the pure -anomers 16 and 21. Here again, the relative configurations at the anomeric centers were unambiguously assigned by 1 H-NMR NOESY experiments (see Supp. Inf.). Likewise, the N 9 -linkage between the purine bases and the anomeric centers were confirmed by 1 H, 13 C-HMBC or HSQC correlation experiments (see Supp.
Inf.). From here, the adenine building block 19 could be obtained by standard dimethoxytritylation (→ 17) followed by TBAF mediated cleavage of the silyl protecting group (→ 18) and phosphitylation. The synthesis of the guanosine building block required the conversion of the 2-amino-6-chloropurine nucleobase into guanine. This was achieved by treatment of 21 with 3-hydroxypropionitrile and TBD followed by DMF-protection of the 2-amino group, yielding the protected guanosine derivative 22. Following the same chemical pathway as above, the synthesis of the guanosine building block 25 was achieved by dimethoxytritylation (→ 23), removal of the silyl protecting group (→ 24) and phosphitylation.
X-ray structure of a 7', Despite considerable efforts we were unable to obtain crystals from the free nucleosides or close intermediates along the synthesis pathway outlined in the previous schemes 1-3. We therefore prepared a 7',5'-bc-T analogue, carrying a p-nitrobenzoate group at O7'. Indeed, this compound could be crystallized and its structure solved (Figure 2 , for crystallographic and synthetic details see Supp. Inf.). [28] Besides establishing final proof for the relative configuration, we also obtained information on the preferred conformation of the bicyclic sugar scaffold. It clearly emerges that the furanose part exists in a perfect 1'-exo conformation while the carbocyclic ring occurs in the 6'-endo configuration thus placing the oxy-substituent at C7' in a pseudoaxial and the 5'OH group in a pseudoequatorial position. This structure matches exactly one of the two low energy conformers determined by ab initio calculations (see Figure 5a ).
Design and synthesis of oligonucleotides:
A series of oligonucleotides with single and multiple incorporations of building blocks 12, 14, 19 and 25 as well as fully modified sequences have been synthesized using classical automated phosphoramidite chemistry (for synthetic and analytical details see experimental section). Oligonucleotides with single and multiple incorporations were primarily prepared to determine the effect of the modifications on the Tm when complexed with complementary DNA and RNA, as well as to determine the Watson-Crick base pairing selectivity. Fully modified oligonucleotides were synthesized to characterize the pairing behavior not only with natural DNA and RNA, but also to investigate the self-pairing of 7',5'-bc-DNA. The main interest here was to determine whether this novel structural DNA analogue can form an independent base-pairing system.
Pairing properties of modified oligodeoxynucleotides with complementary DNA and RNA: To determine the effect of single and multiple modifications on duplex stability we prepared the modified oligodeoxynucleotides ON1-ON11, represented in Table 1 , and measured Tm values for duplexes with complementary DNA and RNA by UV-melting curve analysis.
According to the Tm/mod data, the impact of single or double modifications on thermal duplex stability is relatively moderate. Purine modifications (ON6, 7) tend to destabilize duplexes with complementary DNA but show a slight increase in Tm with complementary RNA. Within the pyrimidine series there is, however, more variability. Modified thymidine nucleosides (ON1-3) typically lead to a small depression of Tm with RNA as complement while no clear trend with DNA is observed. Interestingly, both cytosine modifications (ON4, 5, 8-10) significantly stabilize duplexes with complementary DNA while having less effect on the Tm with complementary RNA. As observed previously, the stabilizing effect is more pronounced for the 5-methyl cytosine nucleosides which is in agreement with its known potential to reinforce stacking interactions with neighboring base-pairs.
To determine the base-pairing selectivity we measured Tms of ON1 in complex with complementary DNA having all three possible mismatched bases opposing the site of modification (Supp. Inf., Table S1 ). The Tms of the mismatched duplexes are lower by 5.1 to 13°C with the G/T wobble pair, as expected, being least destabilizing. These data compare well with the fully natural mismatched series, indicating no significant change in base pairing selectivity of the modification.
Pairing properties of fully modified oligonucleotides with complementary DNA and RNA: A fully modified nonamer consisting of pyrimidine bases only (ON12) as well as 3 dodecamers (ON13-15) containing all four bases were prepared to test their affinity to complementary DNA or RNA in either the antiparallel or parallel orientation. Form the corresponding Tm data (Table 2) it becomes clear that binding is generally weak. Even under high salt (1 M NaCl) conditions, no melting transition could be observed for ON12 with the antiparallel DNA or RNA complement in the temperature range from 5 -80°C, suggesting that no duplex was formed. However, with the longer dodecamers ON13-15, transitions were observed with complementary antiparallel DNA and RNA. The Tms of these duplexes are roughly 30°C lower as compared to the natural control duplexes, amounting to an average Tm/mod of -2.5°C. This was not expected from the Tm experiments of single incorporations ( Table 1 ) and highlights the importance of fully modified oligonucleotides when characterizing novel pairing systems. Importantly, no signs of duplex formation were f ound with the corresponding parallel DNA and RNA complements. This clearly demonstrates that 7',5'-bc-DNA is still able to communicate with the natural nucleic acids via antiparallel duplex structures, albeit on a substantially lower affinity level.
Self-pairing of 7', ON14 has been designed to be the antiparallel and ON15 to be the parallel complement to ON13. With this it was possible to investigate self-pairing of 7',5'-bc-DNA in both orientations. It turned out that the antiparallel duplex ON13·ON14 showed a classical sigmoidal duplex melting behavior ( Figure 3 ) with a Tm of 54.5°C, while the constituting single strands on their own did not as evidenced by Tm-and CD-analysis (see Supp. Inf., Figure   S5 ). The Tm is higher by 5.4°C compared to the natural duplex of the same sequence. Interestingly the hyperchromicity at 260 nm of the 7',5'-bc-DNA duplex amounts to only 20% of that of the natural duplex. This indicates significantly different stacking arrangement of the bases in both duplex conformations. In the parallel orientation (ON13·ON15) no transition could be found demonstrating the inability of parallel duplex formation in 7',5'-bc-DNA.
Thermodynamic data of duplex formation: We determined transition enthalpies and entropies for the duplex ON13·ON14 and the corresponding natural duplex by curve fitting to the experimental melting curves in analogy to known methods (Table 3 ). [29] These data suggest that the natural duplex is enthalpically stabilized while the 7',5'-bc-DNA duplex is entropically favored. This matches with previous findings in the bc-DNA series and hints to conformational restriction of the 7',5'-bc-DNA backbone as the origin of the entropic stabilization. The free enthalpies of duplex formation (G) are in line with the Tm data which qualify them as a measure for thermodynamic duplex stability.
CD-spectroscopy:
To gain insight into the structural properties of the homo 7',5'-bc-DNA duplex and the hybrid 7',5'-bc-DNA/DNA duplex we measured CD-spectra and compared them with that of the corresponding natural DNA duplex ( Figure 4 ). As expected, the natural duplex shows the classical features of a B-DNA duplex. The homo 7',5'-bc-DNA duplex, however, has a CD signature that is significantly different from that of A-or B-type double helices. It is characterized by two minimum ellipticities around 215 and 265 nm with a maximum at 243 nm. The hybrid duplex carries a signature which is closer to that of the DNA duplex. Compared to B-DNA, the minimum ellipticity at 260 nm is red shifted by about 15 nm while the maximum ellipticity at 288 nm is red-shifted by about 7 nm and associated with a loss of intensity. The differences in the three CD spectra thus indicate differential arrangements of the bases within the basestack, induced by the change in backbone geometry of each strand. This agrees with the differential hyperchromicities of the two pairing systems in the corresponding UV-melting curves ( Figure 3 ).
Molecular modelling: To gain insight into the possible helix structures formed by 7',5'-bc-DNA, we performed extensive molecular modeling and dynamics simulation experiments. We first performed a conformational analysis at the Hartree-Fock ab initio level, on the four 7',5'-bc-nucleosides with the bases A, G, T and 5-Me C (see Supp. Inf., Figure S1 -S3).
These calculations showed similar energy profiles for each monomer with two distinct minimum energy conformations each. The first conformer ( Figure 5a ) shows a nearly perfect C1'-exo (S-type) pucker in the furanose subunit and a C6'endo conformation in the carbocyclic ring. In this conformation, the C5' hydroxyl group is in a pseudoequatorial position, orienting the torsion angle γ (C4'-C5') in a "non-natural" antiperiplanar arrangement. The second conformer (Figure 5b) also shows an S-type furanose conformation (C2'-endo sugar pucker). However, the carbocyclic ring is adopting a C6'-exo conformation, orienting the C5' hydroxyl group in a pseudoaxial position. Consequently, the  angle is restored to a more "natural" synclinal arrangement. Interestingly, the potential energy surface (PES) of the C6'-exo conformation ( Figure 5d ) shows a steep convergence toward the minimum, demonstrating structural rigidity, while the C6'-endo conformation seems to allow more flexibility, resulting in a flatter PES ( Figure 5c ). In terms of stability, the C6'-exo conformer is lower in energy in vacuo (between 0.6 to 1.5 kcal/mol, depending on the nucleobase), while the C6'-endo conformer is slightly more stable if solvated in water (between 0.0 to 0.5 kcal/mol) (Supp. Inf., Table S2 .). Therefore, both structures are likely candidates for defining the conformation of the double helix.
The structures of the previously synthesized 7',5'-bc-DNA, 7',5'-bc-DNA/DNA and natural DNA duplexes were then investigated by molecular dynamics simulations on a 60 ns trajectory. The atomic charges of the four nucleoside units were calculated using the R.E.D. III.5 tools package [30] and were added into the Amber94 force field. 7',5'-bc-DNA strands were constructed starting from natural DNA in B-conformation. Simulation of the 7',5'-bc-DNA homo duplex showed a rapid convergence toward a stable right handed helix ( Figure 6a ). This structure possesses an overall shape relatively close to natural B-DNA (Figure 6c ), despite a slightly less coiled helix (average of 12.8 bases per turn for 7',5'bc-DNA and 11.4 for DNA) and a significantly wider minor groove (13.2 Å for 7',5'-bc-DNA and 6.7 Å for DNA).
Compared to DNA, the 7',5'-bc-DNA homo-duplex seems to be stabilized by an increased base-stacking area with a calculated average overlap between bases of 9.40 Å 2 for 7',5'-bc-DNA and 6.77 Å 2 for DNA.
In the 7',5'-bc-DNA homo-duplex the nucleosides surprisingly adopt alternating C6'-exo and C6'-endo conformations along the nucleotide chain in both strands. As a consequence, the γ angles switch between the +sc and ap arrangement in an alternating manner (Figure 6g ), differing strongly from the expected regular +sc arrangement found in natural DNA duplex ( Figure 6i ). This alternating pattern is also apparent in the pseudorotation phase angle P adopted by the furanose rings ( Figure 6j ), leading to a O4'-endo, C1'-exo pucker for the C6'-endo conformers, or a C1'-exo, C2'-endo pucker for the C6'-exo conformers. Interestingly, the conformational restriction induced by the bicyclic structure is well reflected in the distribution of the pseudorotation phase angles. While the more flexible 2'-deoxynucleosides span a wide spectrum of P-angles (Figure 6k ), the 7',5'-bc-nucleosides are locked into two discrete populations. This is in agreement with the reduced entropy contribution to the free enthalpy of duplex formation as calculated from the UV-melting curves.
In the hybrid 7',5'-bc-DNA/DNA duplex, the more rigid bc-DNA strand adopts a conformation similar as in the fully modified system. Interestingly, the DNA strand also shows a partial switch of the  angles to the non-canonical ap arrangement ( Figure 6h ) highlighting the adaptability of the more flexible DNA-strand to the more rigid 7',5'-bc-DNA strand. The need for conformational adaption of the DNA backbone may also explain the difficulties in cross-pairing between the two backbone types.
To find a rationale for the differential effect of single substitutions of 7',5'-bc-nucleosides with different bases on duplex stability, we also performed molecular dynamics simulations on duplexes of DNA with ON2, ON5, ON6 and ON7 (see Supp. Inf., Figure S4 ). A correlation could be observed between 7',5'-bc-nucleosides favoring the C6'-exo conformation and an increase in duplex stability ( Figure 7 ). These data demonstrate that a displacement of the backbone linkage from the 3' to the 7' position, and in consequence alterations of the  and  angles (denominated in analogy to the DNA structural descriptors), is well tolerated when the  angle is conserved in a natural arrangement. But such modifications become destabilizing when the  angle is oriented in an ap arrangement. Therefore, the orientation of the  angle could be an important parameter for developing nucleic acid like base-pairing systems that are orthogonal to DNA.
Conclusions
Inspired by the 2',5'-DNA system we decided to explore an alternative, unnatural DNA topology in which the point of attachment of the nucleotide unit is shifted from the 3'-position to the 7'-position (7', . This topological shift is unique to the scaffold of bicyclo-DNA and cannot be attained by the natural ribofuranose structure. We have succeeded in finding a convenient synthetic access to the nucleoside building blocks of 7',5'-bc-DNA with all canonical nucleobases as well as to the corresponding oligonucleotides. Single substitutions in DNA/DNA or DNA/RNA duplexes with this modification do generally not inflict strongly with duplex stability, indicating that isolated structural perturbations arisi ng from the shift of the phosphodiester attachment are relatively well tolerated and compensated by the surrounding natural nucleotides. This is somehow different from single substitutions with the simple 3'-methylene homologue of DNA, [23] which shows substantial destabilization, most likely due to the missing conformational restriction as compared to 7',5'-DNA. The accuracy of base-pairing is also maintained in these cases, as mismatch formation is associated with similar destabilization of duplexes as for natural DNA.
More of interest is the pairing behavior of fully modified 7',5'-bc-DNA. The affinity of such oligonucleotides to complementary DNA and RNA is strongly reduced to inexistent while 7',5'-homo duplex formation readily occurs with similar thermal and thermodynamic characteristics as for DNA. Similar to the case of natural DNA, only antiparallel strand alignment is tolerated in duplexes. This is not obvious given the quasi C2 symmetry of the 7'-, and 5'-substituents along a pseudo symmetry axis running through the centers C1' and C6' and thus lying in the plane of a base-pair.
A structural rationalization of the differences in stability of homo-and hetero duplexes can be inferred from molecular modeling studies that revealed a pattern of alternative 6'exo/6'-endo conformations in consecutive nucleotides of the bicyclic scaffold. This backbone structure seems to be relatively rigid and also occurs in mixed, 7',5'-bc-DNA/DNA duplexes. In these mixed duplexes, the 7',5'-bc-DNA strand drives the DNA complement in a higher energy conformation in which the torsion angles  of consecutive nucleotides partially oscillate between the +sc and the ap arrangement, resulting in a drop of duplex stability. Thus, 7',5'-bc-DNA constitutes an artificial genetic system that can still weakly crosspair with natural nucleic acids but that shows a competitive preference for complements of its own backbone type. This promiscuity may be exploited in the sense that genetic information can be transferred from the real DNA world into an unnatural 7',5'-bc-DNA world provided there exists a set of DNA polymerases that accept both genetic building blocks as substrates and operate in a read and write mode. This could then be the entry into two orthogonal genetic systems that could be manipulated independently.
Experimental Section
General procedures: All reactions were performed in dried glassware and under an inert atmosphere of Argon. Anhydrous solvents for reactions were obtained by filtration through activated alumina or by storage over molecular sieves (4 Å) . Colum chromatography (CC) was performed on silica gel (SiliaFlash P60, 40-63 um, 60 Å). Methanol used for CC was of HPLC grade, all other solvents used for CC were of technical grade and distilled prior to use. Thin-layer chromatography was performed on silica gel plates (macherey-nagel, precoated TLC-plates sil G-25 UV254). Compounds were visualized under UV-light or by dipping in a p-Anisaldehyde staining solution [p-Anisaldehyde (3.7 mL), glacial acetic acid (3.7 mL), concd sulfuric acid (5 mL), ethanol (135 mL)] followed by heating with a heat gun.
NMR spectra were recorded at 300 or 400 MHz ( 1 H Ethyl (E and Z, 1'R,5'S,7 'R)- (7'-hydroxy-3',3'-dimethyl-2',4'-dioxabicyclo[3.3 .0]oct-6'-ylidene)acetate (2a/b) : A solution of the epoxide 1 (4.46 g, 18.4 mmol) in dry THF (100 mL) was cooled down to -78°C. Then LiHMDS (1M in THF, 22.1 mL, 22.1 mmol) was slowly added.
The solution was stirred for 2 hours at -78°C before being allowed to warm to rt and neutralized with addition of 1M aqueous HCl (22.1 mL). The mixture was then diluted with EtOAc (100 mL) and THF was removed under reduced pressure. The mixture was then washed with 0.5 M NaH2PO4 (50 mL) and aqueous phase extracted with EtOAc (2 X 50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/hexane 3:1) to yield the two isomers 2a/b (3.30 g, 74%) as a slightly yellow solid. Compound 2a: Rf = 0.37 (EtoAc/hexane 1:1); 1 H NMR (300 MHz, CDCl3) δ 6.07 -5.98 (m, 1H, H-C (2) (1)), 167.43 (C(6')), 120.13 (C(2)), 111.75 (C(3')), 81.62 (C(5')), 78.08 (C(1')), 70.85 (C(7')), 61.25 (CH2CH3) Ethyl (1'R,5'S,6'S,7 'R)- (7'-hydroxy-3',3'-dimethyl-2',4'-dioxabicyclo[3.3 .0]oct-6'-yl)acetate (3): To a solution of the alcohols 2a/b (12.65 g, 52. 2 mmol) and nickel chloride hexahydrate ( 2.48 g, 10.4 mmol) in EtOH (300 mL) was added portionwise sodium borohydride ( 9.88 g, 261 mmol) at 0°C. The resulting dark solution was stirred for 30 min at 0°C and 90 min at rt. Then EtOH was carefully concentrated under reduced pressure, the resulting solid diluted with EtOAc (200 mL) and the excess of NaBH4 quenched by addition of water (100 mL) at 0°C followed by stirring at rt for 30 min. The two phases were then separated. Organic phase was washed with water (100 mL).
Aqueous phases were then combined, filtered and extracted with EtOAc (2 X 100 mL). The combined organic phases were dried over MgSO4, filtered and concentrated. The crude product was purified by CC (EtOAc/hexane 2:1) to yield 3 (11.4 g, 90%) as a white solid. Ethyl (1'R,5'S,6'S,7 'R)- (7'-(tert-butyldiphenylsilyl) oxy)- 3',3'-dimethyl-2',4'-dioxabicyclo[3.3 .0]oct-6'-yl)acetate (4): To a solution of the alcohol 3 (2.50 g, 10.2 mmol), N-methylimidazole (12.6 g, 153 mmol) and iodine (7.80 g, 30.6 mmol) in dry THF (60 mL) was added dropwise tert-butyl(chloro)diphenylsilane (3.0 mL, 11.2 mmol) at rt. The solution was stirred for 3 hours at rt and then THF was evaporated, the mixture diluted with EtOAc (50 mL) and washed with 10% aqueous Na2O3S2 (2 X 40 mL). Aqueous phases were then combined and extracted with EtOAc (50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/hexane 1:10) to yield 4 (5. 1'R,5'S,6'S,7'R)-(7'-(tert-butyldiphenylsilyl) oxy)- 3',3'-dimethyl-2',4'-dioxabicyclo[3.3 .0]oct-6'-yl)acetaldehyde (5) : A solution of the ester 4 (8.56 g, 16.3 mmol) in dry DCM (120 mL) was cooled down to -78°C and then DiBAL-H (1M in cyclohexane, 18 mL, 18 mmol) was slowly added. The solution was further stirred at -78°C for 90 min before being allowed to warm to rt. Reaction was quenched by addition of 0.5 M aqueous NaH2PO4 (100 mL). The organic phase was separated and aqueous phase was further extracted with DCM (2 X 100 mL).
The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/hexane 2:10 to 2:1) to yield 5 (6.36 g, 89%) . Data for 5: Rf = 0.65 (EtOAc/hexane 2:1); 1 H NMR (300 MHz, CDCl3) δ 9.72 (s, 1H, H-C (1) (6): To a solution of the aldehyde 5 (13.73 g, 31.31 mmol) in MeCN (170 mL) and H2O (19 mL) was added Indium III trifluoromethanesulfonate (703 mg, 1.25 mmol). The solution was stirred for 48 hours, and then solvents were removed under reduced pressure and coevaporated with toluene. The residue was dissolved in dry MeOH and stirred for 6 hours. After evaporation of solvent, the crude product was purified by CC (EtOAc/hexane 3:10) to yield a mixture of 6 (10.50 g, 81%) in an anomeric ratio α/β ≈ 4:1 as a colorless oil. Data for 6: Rf = 0.53 (EtOAc/hexane 1:1); 1 (3aR,4R,6R,6aS)-4-((tert-butyldiphenylsilyl)oxy)-3a, 5,6,6a-tetrahydro-4H-cyclopenta[b] furan- 6-ol (8) : To a solution of the sugar 6 (2.08 g, 5.04 mmol) in dry DCM (35 mL) was added 2,6-lutidine (2.95 mL, 25.2 mmol) at 0°C. After stirring for 20 min at 0°C, TMSOTf (2.73 mL, 15.1 mmol) was added dropwise, then the solution was allowed to warm to rt and was further stirred for 60 min. The reaction was then quenched by addition of satd NaHCO3 (40 mL). The organic phase was separated and aqueous phase was further extracted with DCM (3 X 30 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The resulting product was dissolved in dry THF (35 mL), cooled down to 0°C, and TBAF (1M in THF, 5.6 mL, 5.6 mmol) was added. After stirring for 10 min at 0°C, the solution was diluted with satd NaHCO3 (30 mL) and extracted with DCM (4 X 40 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/hexane 1:4) to yield the glycal 8 (1.76 g, 92%) . Data for 8: Rf ( ((3aR,4R,6R,6aS )-6-(bis(4-methoxyphenyl)(phenyl)methoxy)-3a, 5,6,6a-tetrahydro-4H-cyclopenta[b] furan-4-yl)oxy)(tertbutyl)diphenylsilane (9): To a solution of glycal 8 (1.34 g, 3.52 mmol) and DMTr-Cl (1.43 g, 4. 23 mmol) in a mixture of dry DCM (15 mL) and dry 2,6-lutidine (15 mL) was added portionwise silver triflate (1.13 g, 4.40 mmol) , resulting in a deep red suspension. After stirring for 2 hours at rt, an additional portion of DMTr-Cl (239 mg, 0.705 mmol) was added. The suspension was further stirred for 2 hours and then was filtered. The organic phase was washed with satd NaHCO3 (100 mL) and then the aqueous phase was extracted with DCM (3 X 30 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/hexane 1:7, +0.5 % Et3N) to yield the protected glycal 9 (2.24, 93%) as a white foam. Data for 9: Rf = 0.59 (EtOAc/hexane 1:2); 1 12.4, 4.2 Hz, 1H, ), 1.28 (dd, J = 12.7, 5.4 Hz, 1H , H-C(5)), 1.11 (s, 9H, (CH3)3-C-Si); 13 C NMR (75 MHz, CDCl3) δ 158.67 (MeO-C-arom), 147.61 (C(2)), 146. 26, 137.36, 135.81, 134.17, 130.48, 129.83, 129.81, 128.37, 127.98, 127.76, 127.73, 126.79, 113.32, , 100.29 (C(3)), 86.96 (C(Ph)3), 84.95 (C(6a)), 76.17 (C(6)), 76.07(C(4)), 55.26 (MeO-DMTr), 55.11 (C(3a)), 37.32 (C (5) (3aS,4R,6R,6aS )-6-(bis(4-methoxyphenyl)(phenyl)methoxy)-3a, 5,6,6a-tetrahydro-4H-cyclopenta[b]furan-4-ol (10) : To a solution of glycal 9 (2.23 g, 3.27 mmol) in dry THF (20 mL) was added TBAF (1M in THF, 20 mL, 20 mmol) at rt. The solution was stirred for 20 h and then was diluted with satd NaHCO3 (100 mL) and extracted with DCM (3 X 80 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (0.5% MeOH in DCM, +0.5 % Et3N) to yield 10 (1.45 g, quant.) as a white foam. Data for 10: Rf = 0.44 (EtOAc/hexane 1:1); 1 H NMR (300 MHz, 2H, 4H, Harom), 7.21 (dd, J = 10.7, 5.3 Hz, 2 H, 1H, 4H, 29 -4.14 (m, 2H, H-C(6) , H-C(6a)), 3.71 (s, 6H, MeO), 3.65 (d, J = 3.5 Hz, 1H, ), 2.87 (d, J = 7.9 Hz, 1H, H-C(3a)), 1.59 (ddd, J = 13.2, 11.6, 4.3 Hz, 1H, ), 1.05 -0.95 (m, 2H, H-C(5), OH); 13 C NMR (75 MHz, CDCl3) δ 158.54 (MeO-C-arom), 147.64 (C(2)), 145.82, 137.12, 137 .08 (C-arom), 130. 26, 128.29, 127.81, 126.71, 3'S, 5'R, methyl]-β-D-ribofuranosyl} thymine (11) : To a solution of glycal 10 (1.45 g, 3.27 mmol) in dry DCM (45 mL), at 0°, was added dropwise BSA (2.0 mL, 8.18 mmol) and then the solution was allowed to warm to rt. After stirring for 45 min, Thymine (595 mg, 4.91 mmol) was added and the reaction was further stirred for 60 min at rt. The mixture was then cooled down to 0° C and N-iodosuccinimide (875 mg, 3.92 mmol) was added. After stirring for 3 h at 0° C and for 4 h at rt, the reaction mixture was diluted with EtOAc (100 mL) and subsequently washed with a 10% aq solution of Na2S2O3 (100 mL) and satd NaHCO3 (100 mL). Aqueous phases were combined and extracted with DCM (3 X 50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was dissolved in dry toluene (45 mL) and then Bu3SnH (1.32 mL, 4.91 mmol) and azoisobutyronitrile (AIBN, 53 mg, 0.33 mmol) were added at rt. After heating at 70°C for 30 min, the mixture was cooled down to rt and TBAF was added (1M in THF, 6.5 mL, 6.5 mmol). The solution was further stirred for 25 min and was diluted with satd NaHCO3 (100 mL) and extracted with DCM (4 X 70 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (3% MeOH in DCM, +0.5 % Et3N) to yield 11 (1.45 g, 73% over two steps) as a white foam. Data for 11: Rf = 0.29 (6% MeOH in DCM); 1 H NMR (400 MHz, CDCl3) δ 9.37 (br, 1H, H-N(3)), 7.83 (d, J = 1.1 Hz, 1H, H-C(6)), 2H, 4H, 7.28 (t, J = 7.7 Hz, 2H, 7.21 (t, J = 7.2 Hz, 1H, 6.84 (dd, J = 8.9, 1.2 Hz, 4H, 5.91 (dd, J = 8.0, 5.5 Hz, 1H , H-C(1')), 4.25 (dt, J = 10.8, 6 .0 Hz, 1H, H-C(5')), 4.13 -4.08 (m, 1H, H-C(4')), 3.86 (d, J = 3.4 Hz, 1H , H-C(7'), 3.79 (s, 6H, MeO), 2.70 (ddd, J = 12.8, 10.2, 5.5 Hz, 1H , H-C(2')), 2. 61 (dd, J = 16.9, 8.2 Hz, 1H , H-C(3')), 1.84 (d, J = 0.8 Hz, 3H, ), 1.80 (br, 1H, OH), 1.60 (ddd, J = 14.2, 10.5, 4.2 Hz, 1H , H-C(6')), 1.33 (dt, J = 12.9, 8.0 Hz, 1H,  H-C(2')), 1.14 (dd, J = 13.7, 6.1 Hz, 1H, ); 13 C NMR (101 MHz, CDCl3) δ 164.17 (C(4)), 158.64 (MeO-C-arom), 150.47 (C(2)), 145.65, 136.85, 136.71 (C-arom), 135.52 (C(6) ), 130.20, 128.12, 127.91, 126.90, 113.22, 110.69 (C(5) ), 87.21 (C(Ph)3), 86.57 (C(1') ), 82.02 (C(4')), 74.19 (C(5')), 74.13 (C(7')), 55.25 (MeO-DMTr), 49.40 (C(3')), 38.51 (C(6')), 37.64 (C(2')), 12.58 (Me-C (5)); ESI + -HRMS m/z calcd for C33H34O7N2Na ([M + Na] + ) 593.2258, found 593.2250. (3'R,5'R,7' methyl]-β-D-ribofuranosyl} thymine (12) : To a solution of the nucleoside 11 (232 mg, 0.406 mmol) and 5-(ethylthio)-1H-tetrazole (90 mg, 0.69 mmol) in dry DCM (10 mL) was added dropwise 2-cyanoethyl N,N,N′,N′-tetraisopropylphosphordiamidite (0.26 mL, 0.81 mmol) at rt. After stirring for 30 min, the reaction mixture was diluted with DCM (50 mL) and washed with satd NaHCO3 (2 X 30 mL) and satd NaCl (30 mL) . Aqueous phases were combined and extracted with DCM (50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (1.8% MeOH in DCM, +0.5 % Et3N) to yield 12 (219 mg, mixture of two isomers, 70%) as a white foam. Data for 12: Rf = 0.68 (6% MeOH in DCM); 1 145.58, 145.52, 136.76, 136.71, 136.69, 136.60 (C-arom), 135.49, 135.35 (C(6) ), 130. 21, 130.16, 128.17, 128.13, 127.88, 126.91, 126 .89 (CH-arom), 117.49 (OCH2CH2CN), 113.18 (CH-arom), 110.74 (C(5)), 87.27, 87.25 (C(Ph)3), 86.58, 86.45 (C(1')), 81.79, 81.68 (C(4')), 76.02 , 75.50 ( JC, P = 16.5, 15.7 Hz, C(7') ), 74.22 (C(5')), 58. 26, 58.06, 57.87 (OCH2CH2CN), 55.26, 48.85, 48 .62 ( JC,P = 2.6, 5.0 Hz, C(3')), 43. 10, 43.04 ( JC, P = 12.3, 12.4 Hz (Me2CH) 2N), 37.78 ( JC,P = 5.3 Hz C(6')), 37.62, 37.48 (C(2')), 37.41 ( JC,P = 3.6 Hz C(6')), 24.57, 24.53, 24.50, 24.46, 24.44, 24.39, 24.37 (Me2CH)2N) , 20.35, 20.25 ( JC,P = 7.1, 7.0 Hz, OCH2CH2CN), 12.58, 12.41 (7s, ); 31 3'S, 5'R, methyl]-β-D-ribofuranosyl}- 5methylcytosine (13) : To a solution of the nucleoside 11 (302 mg, 0.530 mmol) in dry MeCN (5 mL) was added dropwise BSA (0.31 mL, 1.27 mmol) at 0°, and then the solution was stirred overnight at rt. In another flask, a suspension of 1,2,4-triazole (1.28 g, 18.55 mmol) in dry MeCN (50 mL) was cooled down to 0° C and POCl3 (0.40 mL, 4.2 mmol) and Et3N (2.96 mL, 21.2 mmol) were added. The suspension was stirred for 30 min at 0° C, and then the previous prepared solution of the silylated compound 11 was added to the suspension and the mixture was further stirred for 5 h at rt. Reaction was quenched with addition of satd NaHCO3 (10 mL), MeCN removed under reduced pressure and the resulting mixture diluted with satd NaHCO3 (35 mL) and extracted with DCM (3 X 40 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was then dissolved in a mixture of 1,4dioxane (10 mL) and concd NH4OH (10 mL). After stirring for 2 h at rt, the mixture was reduced to half of its volume in vacuo, diluted with satd NaHCO3 (30 mL) and extracted with DCM (4 X 30 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was then dissolved in dry DMF (13 mL), Et3N (90 μL, 0.64 mmol) followed by Bz2O (300 mg, 1.33 mmol) were added at rt and the solution was stirred overnight. The resulting brown solution was quenched by careful addition of satd NaHCO3 (50 mL) and extracted with DCM (4 X 50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The (6)), 136.99, 136.83, 132.41, 130.22, 129.89, 128.16, 128.14, 127.95, 126.94, , 111.57 (C(5)), 87.34 (C(Ph)3), 87.32 (C(1')), 82.57 (C(4')), 74.30 (C(5')), 74.16 (C(7')), 55.27 (MeO-DMTr), 49.56 (C(3')), 38.52 (C(6')), 38.00 (C(2')), 13.63 (Me-C (5) 4'dimethoxytriphenyl )methyl]-β-D-ribofuranosyl}- 5-methylcytosine (14) : To a solution of the nucleoside 13 (276 mg, 0.409 mmol) and 5-(ethylthio)-1H-tetrazole (69 mg, 0.53 mmol) in dry DCM (10 mL) was added dropwise 2-cyanoethyl N,N,N′,N′tetraisopropylphosphordiamidite (0.20 mL, 0.61 mmol) at rt. After stirring for 60 min, the reaction mixture was diluted with DCM (50 mL) and washed with satd NaHCO3 (2 X 30 mL) and satd NaCl (30 mL) . Aqueous phases were combined and extracted with DCM (50 mL).
(3aR,4R,6R,6aS)-4-((tert-butyldiphenylsilyl)oxy)-2-methoxyhexahydro-2H-cyclopenta[b]furan-6-ol
The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/hexanne 2:3, +0.5 % Et3N) to yield 14 (268 mg, mixture of two isomers, 75%) as a white foam. Data for 14: Rf = 0.77 (5% MeOH in DCM); 1 H NMR (400 MHz, CDCl3) δ 13.32 (s, 1H, NH), 2H, 1H, C(6) ), 7. 61 -7.51 (m, 3H, H-arom), 7.51 -7.40 (m, 6H, H-arom), 7.37 -7.29 (m, 2H, H-arom), 7.29 -7.20 (m, 1H, H-arom), 6.92 -6.82 (m, 4H, H-arom), 6.07 -5.87 (m, 1H , H-C(1')), 4.24 (dq, J = 11.7, 5.8 Hz, 1H, ), 4.13 -4 .00 (m, 1H, H-C(4')), 3.94 (ddd, J = 14.5, 10.5, 2.8 Hz, 1H , H-C(7')), 3.83, 3.82 (2s, 6H, MeO), 3.69 (m, 2H, OCH2CH2CN), 2H, (Me2CH) 2N), 2.91 -2.70 (m, 2H, H-C(2'), H-C(3')), 2.57, 2.53 (2t, J = 6.3
Hz, 2H, OCH2CH2CN), 2.08, 1.99 (2d, J = 0.6 Hz, 3H, ), 1.72 -1.56 (m, 1H, H-C(6') ), 1.54 -1.36 (m, 2H, H-C(2') , H-C(6')), 1.10 (m, 12H, (Me2CH)2N); 13 C NMR (101 MHz, CDCl3) δ 179.54 (CONH), 159.98 (C(4)), 158.69 (MeO-C-arom), 147.90 (C(2)), 145.58, 145.54 (C-arom), 137.30, 136.93 (C(6) ), 136.81, 136.80, 136.73, 136.70, 136.67, 132.37, 132.35, 130.22, 130.17, 129.89, 128.17, 128.15, 128.11, 127.93, 117.49 (OCH2CH2CN), 111.60 (C(5) ), 87.36, 87.35 (C(Ph)3), 87.33, 87.25 (C(1')), 82.33, 82.25 (C(4')), 76.05, 75.52 ( JC, P = 16.4, 15.6 Hz, C(7') ), 74.32 (C(5')), 58. 18, 57.98 (JC, P = 19.5 Hz OCH2CH2CN), 55.28, 48.93, 48.72 ( JC, P = 2.7, 4.9 Hz, C(3') ), 43.11, 43.05 ( JC, P = 12.4 Hz (Me2CH) 2N), 38.02, 37.88 (C(2')), 37.74, 37.40 ( JC,P = 5.3, 3.4 Hz, C(6')), 24.58, 24.54, 24.50, 24.47, 24.40, 24.38 (6s, Me2CH)2N) , 20.36, 20.26 ( JC,P = 7.1 Hz, OCH2CH2CN),), 13.66, ); 31 (3aR,4R,6R,6aS)-4-((tert-butyldiphenylsilyl)oxy)-2-methoxyhexahydro-2H-cyclopenta[b] furan-6-yl acetate (7) : To a solution of sugar 6 (3.35 g, 8.12 mmol) and 4-dimethylaminopyridine (1.29 g, 10.6 mmol) in dry DCM (100 mL) was added acetic anhydride (3.8 mL, 41 mmol) at rt. After stirring for 2 h, reaction was quenched by slow addition of satd NaHCO3 (10 mL). The mixture was then diluted with satd NaHCO3 (50 mL) and extracted with DCM (3 X 50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc/Hexanne 1:2) to yield a mixture of 7 (3.53 g, 96%) in an anomeric ratio α/β ≈ 4:1 as a colorless oil. Data for 7: Rf = 0.42 (EtOAc/hexane 1:2); 1 H NMR (400 MHz, 4H, 6H, 5.41 (dt, J = 11.0, 5.6 Hz, 0.8H, ), 5.28 (ddd, J = 11.7, 6.6, 5.2 Hz, 0.2H, ), 4.99 (d, J = 4.8 Hz, 0 .8H, H-C(2)), 4.89 -4.81(m, 0.4H, H-C(2) , H-C(6a)), 4.76 -4.69 (m, 0 .8H, H-C(6a)), 4.11 (d, J = 5.1 Hz, 0.2H, ), 3.90 (d, J = 4 .0 Hz, 0.8H, H-C(4)), 3.27, 3.24 (2s, 3H, MeO), 2.81 (dd, J = 16.6, 7.6 Hz, 0.8H, ), 2.60 (dd, J = 10.1, 7.0 Hz, 0.2H, H-C(3a)), 2. 30 -2.18 (m, 0.2 H, H-C(5) ), 2. 12, 2.10 (2s, J = 4.7 Hz, 3H, MeCO2), 2.8H, , H-C(3)), 1.24 (ddd, J = 12.9, 7.6, 3.7 Hz, 1H , H-C(3)), 1.07 (s, 9H, (CH3)3-C-Si); 13 C NMR (75 MHz, CDCl3) δ 170.75, 170.66 (MeCO2), 135.77, 135.73, 133.75, 129.82, 129.74, 127.76, 127.75, 106.19, 106.15 (C(2) ), 83. 17, 79.80 (C(6a) ), 77.49, 76.46 (C(4)), 75.64, 74.41 (C(6) ), 54.34, 54.25 (MeO), 51.48, 50.17 (C(3a) ), 38.05, 37.98 (C (3)), 36.96, 36.21 (C(5) ), 26.95, 26.90 (CH3) 3'R, 5'R, oxy]-2', : To a suspension of sugar 7 (1.86 g, 4.10 mmol) and N 6 -benzoyladenine (1.96 g, 8.20 mmol) in dry MeCN (40 mL) was added BSA (4.00 mL, 16.4 mmol) at rt. After stirring for 25 min, the suspension became a clear solution and then was heated to 70°C. TMSOTf (1.48 mL, 8.20 mmol) was added dropwise and the solution was further stirred for 20 min at 70°C. The solution was then cooled down to rt, quenched with addition of satd NaHCO3 (100 mL) and extracted with EtOAc (4 X 50 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (2% MeOH in DCM) to yield a mixture of 15 (1.74 g, 64%) in an anomeric ratio α/β ≈ 4:1 as a white foam. Data for 15: Rf = 0.33 (EtOAc/hexane 4:1); 1 H NMR (400 MHz, CDCl3) δ 9.33 (br, 1H, NH), 8.68 (d, J = 5.4 Hz, 0 .8H, H-C(2)), 8.64 (d, J = 5.6 Hz, 0 .2H, H-C(2)), 8.10 (d, J = 1.5 Hz, ), 7.99 (d, J = 7.3 Hz, 2H, 7.95 (s, 0 .8H, H-C(8)), 7.63 (t, J = 8.7 Hz, 4H, H-arom), 7.55 (dd, J = 13.0, 6.4 Hz, 1H, H-arom), 7.50 -7.34 (m, 8H, H-arom), 6.20 (dd, J = 6.3, 2.5 Hz, 0.8H, H-C(1')), 6.05 (t, J = 6.5 Hz, 0.2H, H-C(1')), 5.43 -5.32 (m, 1H , H-C(5')), 5.03 -4.97 (m, 0.8H, H-C(4')), 4.83 (t, J = 6.0 Hz, 0.2H, H-C(4')), 4.14 (br, 0.2H, H-C(7')), 4.08 (d, J = 3.7 Hz, 0.8H, H-C(7')), 3.02 (dd, J = 16.1, 6.6 Hz, 0.8H, H-C(3')), 2.83 (dd, J = 16.9, 7.7 Hz, 0.2H, H-C(3')), 2.59 -2.39 (m, 1H, H-C(2')), 2.18 -2.11 (m, 1H, H-C(6')), 2.07 (d, J = 1.6 Hz, 2.4H, MeCO2), 2.02 (d, J = 1.9 Hz, 0.6H, MeCO2), 2.01 -1.92 (m, 1H, H-C(6')), 1.91 -1.80 (m, 1H, H-C(3')), 1.07 (s, 9H, (CH3)3-C-Si); 13 C NMR (101 MHz, CDCl3) δ 170.57, 170.49 (MeCO2), 164.82 (CONH), 152.50 (C(2)), 151 .27 (C(4)), 149.56 (C(6)), 141.37, 141.06 (C(8)), 135.72, 135.68, 133.67, 133.57, 133.24, 132.73, 130.03, 129.98, 128.80, 128.78, 127.92, 127.86, 127 .85 (CH-arom), 123.61 (C(5)), 87. 19, 86.17 ( C(1') ), 83. 22, 80.96 (C(4'), 76.50, 76 .04 (C(7')), 74.38 (C(5')), 51.07 (C(3')), 37. 29, 37.15, 36.80, 36.60 (C(2'), C(6')), 26. 3'R, 5'R, oxy]-2', : The nucleoside 15 (1.74 g, 2.64 mmol) was dissolved in 0.15 M NaOH in THF/methanol/H2O (5:4:1, 80 mL) at 0°C. The reaction was stirred for 20 min and quenched by addition of NH4Cl (1.06 g). Solvents were then removed under reduced pressure and the product purified by CC (5% isopropanol in DCM) to yield 16 (287 mg, 18%) and its corresponding α anomer (836 mg, 51%) as white foams. Data for 16: Rf = 0.44 (6% MeOH in DCM); 1 H NMR (300 MHz, CDCl3) δ 8.70 (s, 1H, H-C(2)), 8.09 -7.98 (m, 2H, H-arom), 7.97 (s, 1H, H-C(8)), 7.63 (ddd, J = 7.4, 5.7, 1.5 Hz, 4H, 1H, 7.51 (m, 2H, 6H, 6.02 (dd, J = 9.4, 5.5 Hz, 1H, H-C(1')), 4.57 (dd, J = 8.1, 5.0 Hz, 1H, H-C(4')), 4.43 (dd, J = 11.8, 5.3 Hz, 1H , H-C(5')), 4.26 (br, 1H, H-C(7')), 2.78 (q, J = 8.9
Hz, 1H, H-C(3')), 2.32 -1.80 (m, 5H, H-C(2'), H-C(6'), OH), 1.06 (s, 9H, (CH3)3-C-Si); 13 C NMR (101 MHz, CDCl3) δ 164.85 (CONH), 152.56 (C(2)), 151.17 (C(4) ), 149.86 (C(6)), 141. 25 (C(8) ), 135.68 (CH-arom), 133.87, 133.39 (C-arom), 132.78, 129.92, 128.78, 128.01, 127 .78 (CH-arom), 123.51 (C(5)), 87.65 (C(1') ), 82.91 (C(4')), 76.66 (C(7')), 72.54 (C(5')), 50.44 (C(3')), 41.42 (C(6')), 36.17 (C(2')), 26 .89 (CH3)3-C-Si), 19 .03 (CH3)3-C-Si); ESI + -HRMS m/z calcd for C35H38O4N5Si ([M + H] + ) 620.2688, found 620.2671. (3'R, 5'R, oxy]-2', methyl]-β-D-ribofuranosyl} adenine (17) : To a solution of nucleoside 16 (307 mg, 0.495 mmol) in dry pyridine (6 mL) was added DMTr-Cl (503 mg, 1.49 mmol) at rt. The solution was stirred for 1 day and then diluted with satd NaHCO3 (50 mL) and extracted with DCM (3 X 70 mL).
The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC ( (8)), 137.00, 136.85 (C-arom), 135.60, 133.80, 133.69, 132.70, 130.28, 130.25, 129.85, 129.81, 128.84, 128.18, 127.89, 127.71, 127.65, , 123.52 (C(5)), 113. 22, , 87.09 (C(Ph)3), 86.41 (C(1')), 83.52 (C(4')), 76.05 (C(7')), 74.78 (C(5')), 55.20 (MeO-DMTr), 50.43 (C(3')), 38.10 (C(2'), C(6')), 26 .84 (CH3)3-C-Si), 19 .00 (CH3)3-C-Si); ESI + -HRMS m/z calcd for C56H56O6N5Si ([M + H] + ) 922.3994, found 922.3953. (3'S, 5'R, methyl]-β-D-ribofuranosyl} adenine (18) : To a solution of nucleoside 17 (376 mg, 0.408 mmol) in dry THF (9 mL) was added TBAF (1M in THF, 1.22 mL, 1.22 mmol) at rt.
The solution was stirred for 2 days, then was diluted with satd NaHCO3 (25 mL 3H, H-arom), 6.84 (d, J = 8.9 Hz, 4H, H-arom), 6.09 (dd, J = 7.8, 6.2 Hz, 1H, H-C(1')), 4.12 (dt, J = 11.2, 5.8 Hz, 1H, C(5') ), 3.87 -3.79 (m, 2H, C(4'), C(7')), 3.75 (s, 6H, MeO), 2.83 -2.64 (m, 2H, C(2'), OH), 2.58 -2.46 (m, 1H, C(3')), 2.21 (dd, J = 13.9, 7.1 Hz, 1H, C(2')), 1.92 -1.82 (m, 1H, C(6')), 1.29 -1.17 (m, 1H, C(6')); 13 C NMR (75 MHz, CDCl3) δ 165.03 (CONH), 158.57 (MeO-C-arom), 152.40 (C(2)), 151.23 (C(4)), 149.52 (C (6)), 145.68 (C-arom), 141.49 (C (8)), 136.86, 136.84, 133.77 (C-arom), 132.77, 130.22, 128.81, 128.16, 128.02, 127.89, 126 .84 (CH-arom), 123.40 (C (5) 4'dimethoxytriphenyl )methyl]-β-D-ribofuranosyl} adenine (19) : To a solution of the nucleoside 18 (173 mg, 0.253 mmol) and N,Ndiisopropylethylamine (0.18 mL, 1.0 mmol) in dry THF (8 mL) was added N,N-diisopropylchlorophosphoramidite (0.11 mL, 0.50 mmol) at rt. The solution was stirred for 2 hours and then was diluted with satd NaHCO3 (40 mL) and extracted with DCM (4 X 40 mL). The combined organic phases were dried over MgSO4, filtered and evaporated. The crude product was purified by CC (EtOAc, +0.5 % Et3N) to yield 19 (177 mg, mixture of two isomers, 71%) as a white foam. Data for 19: Rf = 0.38, 0.44 (EtOAc); 1 H NMR (400 MHz, CDCl3) δ [a] total strand conc. 2M in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0.
Tables
[b] A,G,T,C denote natural 2'-deoxynucleosides; a,t,g,c corresponds to modified nucleosides, c stands for the modified 5-methyl cytosine nucleoside.
[c] Tm of unmodified duplexes, DNA/DNA: 49.1°C, DNA/RNA: 49.4°C [d] Tm of unmodified duplexes, DNA/DNA: 47.5°C, DNA/RNA: 44.0°C Experimental conditions: total strand conc. 2M in 10 mM NaH2PO4, 1 M NaCl, pH 7.0.
[a] n.m.: not measured. [b] n.d.: not detectable due to formation of a self-structure of the corresponding RNA strand with a Tm of 28°C. Table 3 . Thermodynamic data of duplex formation. 
